Sanofi (SNY) Financials

SNY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 146.7 billion 62.9 billion
Dec. 31, 2025 148.9 billion 64.7 billion
Sept. 30, 2025 152.3 billion 66.0 billion
June 30, 2025 147.3 billion 64.4 billion

SNY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 1.9 billion ?
Dec. 31, 2025 1.9 billion ?
Sept. 30, 2025 5.4 billion ?
June 30, 2025 49.5 million 201.6 million

SNY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 1.8 billion
Dec. 31, 2025 -940.3 million
Sept. 30, 2025 3.3 billion
June 30, 2025 4.6 billion

SNY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 6.4 billion 14.1 billion 2.1 billion
Dec. 31, 2025 9.0 billion 16.7 billion 2.0 billion
Sept. 30, 2025 10.5 billion 13.7 billion 2.2 billion
June 30, 2025 18.1 billion 15.6 billion 2.1 billion

SNY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 2.8 billion
Dec. 31, 2025 2.9 billion
Sept. 30, 2025 2.9 billion
June 30, 2025 2.9 billion

SNY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 2.0 billion 2.9 billion 191.4 million
Dec. 31, 2025 2.2 billion 2.7 billion 2.8 billion -
Sept. 30, 2025 991.6 million 2.2 billion 2.7 billion -
June 30, 2025 - 2.3 billion 3.1 billion 5.3 billion

SNY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 12.9 billion 3.6 billion
Dec. 31, 2025 14.3 billion 4.3 billion
Sept. 30, 2025 15.5 billion 4.0 billion
June 30, 2025 12.7 billion 3.5 billion

SNY

Price: $42.37

52 week price:
42.37
53.36

Dividend Yield: 5.06%

5-year range yield:
0.32%
5.06%

Forward Dividend Yield: 5.72%

Payout Ratio: 109.54%

Payout Ratio Range:
-4406.90%
848.08%

Dividend Per Share: 2.42 USD

Earnings Per Share: 2.32 USD

P/E Ratio: 19.84

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: France

Volume: 337528

Ebitda: 1.5 billion

Market Capitalization: 104.4 billion

Average Dividend Frequency: 1

Years Paying Dividends: 24

DGR3: 4.59%

DGR5: 5.40%

DGR10: 3.30%

DGR20: 30.00%

Links: